Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (221-230 of 355) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Jose-Ramon Conejo-Garcia, et al.
Nature Medicine|May 6, 2014
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumorsGregory T Motz, Stephen P Santoro, Li-Ping Wang, et al.
Biosensors & Bioelectronics|November 13, 2022
A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD<sup>+</sup> metabolismTamara Maric, Arkadiy Bazhin, Pavlo Khodakivskyi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Report on the ISBTC mini-symposium on biologic effects of targeted therapeuticsMichael B Atkins, David Carbone, George Coukos, et al.
Cancer Biology & Therapy|May 28, 2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculatureDimitra Sasaroli, Phyllis A Gimotty, Harsh B Pathak, et al.
Cancer Immunology Research|April 30, 2014
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation studyFiona Simpkins, Aurea Flores, Christina Chu, et al.
Plos One|January 28, 2009
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formationShun Liang, Nuo Yang, Yue Pan, et al.
Cancer Biology & Therapy|February 21, 2014
Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular modelChunsheng Li, Ann-Marie Chacko, Jia Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2014
Development of 124I immuno-PET targeting tumor vascular TEM1/endosialinAnn-Marie Chacko, Chunsheng Li, Madhura Nayak, et al.
Oncoimmunology|October 10, 2015
High-throughput monitoring of human tumor-specific T-cell responses with large peptide poolsMathieu F Chevalier, Sara Bobisse, Carla Costa-Nunes, et al.
Pageof 36

Showing results (221-230 of 355) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Jose-Ramon Conejo-Garcia, et al.
Nature Medicine|May 6, 2014
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumorsGregory T Motz, Stephen P Santoro, Li-Ping Wang, et al.
Biosensors & Bioelectronics|November 13, 2022
A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD<sup>+</sup> metabolismTamara Maric, Arkadiy Bazhin, Pavlo Khodakivskyi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Report on the ISBTC mini-symposium on biologic effects of targeted therapeuticsMichael B Atkins, David Carbone, George Coukos, et al.
Cancer Biology & Therapy|May 28, 2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculatureDimitra Sasaroli, Phyllis A Gimotty, Harsh B Pathak, et al.
Cancer Immunology Research|April 30, 2014
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation studyFiona Simpkins, Aurea Flores, Christina Chu, et al.
Plos One|January 28, 2009
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formationShun Liang, Nuo Yang, Yue Pan, et al.
Cancer Biology & Therapy|February 21, 2014
Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular modelChunsheng Li, Ann-Marie Chacko, Jia Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2014
Development of 124I immuno-PET targeting tumor vascular TEM1/endosialinAnn-Marie Chacko, Chunsheng Li, Madhura Nayak, et al.
Oncoimmunology|October 10, 2015
High-throughput monitoring of human tumor-specific T-cell responses with large peptide poolsMathieu F Chevalier, Sara Bobisse, Carla Costa-Nunes, et al.
Pageof 36